Lumia

Heart and vascular health

5 min read Clinically reviewed · September 28, 2026 Updated: September 28, 2026 PerimenopauseMenopausePostmenopause

Summary

Cardiovascular disease causes far more deaths in women than breast cancer does; yet women do not see it as a real risk for themselves, and the symptoms often run differently. The menopause transition is a turning point at which heart risk clearly rises: the cholesterol profile worsens, blood pressure goes up, abdominal fat increases, and arteries become less elastic. Early menopause raises this risk further. This is information to act on, not to fear: heart risk can be measured at this stage, and it can largely be changed. HRT is not given to protect the heart; but managing lifestyle, blood pressure and cholesterol does protect it.

What is happening?

Estrogen keeps artery walls flexible, protects the cholesterol profile, and limits inflammation and insulin resistance. As that protection fades in the menopause transition, several changes arrive together:

  • Blood lipids: LDL ("bad") cholesterol and triglycerides rise; HDL's protective function declines. This change accelerates around the final period, independently of age.
  • Blood pressure: After menopause the frequency of high blood pressure approaches, then overtakes, that of men.
  • Abdominal fat and insulin resistance: Fat distribution shifts into the abdomen; the risk of diabetes rises (see the separate article on weight and metabolism).
  • Arterial stiffness: The artery wall becomes less elastic, which increases the heart's workload.
  • Sleep and vasomotor symptoms: Frequent, severe hot flashes and disturbed sleep are associated with markers of cardiovascular risk.

Additional risk factors specific to women are also taken into account at this stage: high blood pressure or pre-eclampsia in pregnancy, gestational diabetes, polycystic ovary syndrome, a history of preterm birth, and autoimmune diseases.

What do we know?

  • The menopause transition is a period of risk: The American Heart Association's 2020 scientific statement describes the menopause transition as a period of increasing cardiometabolic risk in women, independent of aging, and recommends starting preventive measures within this window 1.
  • Early menopause increases risk: In a pooled analysis of more than 300,000 women, menopause before the age of 40 was associated with a clear increase in cardiovascular disease risk, and menopause between 40 and 44 with a moderate increase. Each year of earlier menopause increased risk by a small but measurable amount 2.
  • HRT is not given to protect the heart: The evidence does not support starting HRT to prevent heart disease in women without symptoms 3. On the other hand, HRT started for symptoms under the age of 60 or within the first 10 years after menopause does not increase cardiovascular risk and is associated with lower rates of coronary events in observational data; this "timing hypothesis" does not mean HRT is a heart medicine 4 7. The US FDA adopted the same framing in November 2025 when it removed the cardiovascular warning from HRT labels: the benefit-risk balance depends on the age at which it is started, and HRT is not prescribed for heart protection 6.
  • Risk can be calculated and managed: European guidelines recommend calculating 10-year risk with scores based on age, sex, smoking, blood pressure and cholesterol, and treating accordingly with lifestyle measures and, where needed, medication (blood pressure, a statin) 5. Postmenopausal women benefit from this assessment as much as men do, but receive it less often.
  • Symptoms can be different: In women a heart attack may present with breathlessness, unusual fatigue, nausea, or jaw or back pain rather than classic chest pain; this is one of the reasons diagnosis is delayed 1.

What does this give you?

  • Know your numbers: Blood pressure, LDL cholesterol, fasting glucose or HbA1c, waist circumference. The menopause transition is the right time to start having these measured regularly; your doctor decides how often.
  • Tell your history: Pregnancy complications and early menopause do not appear in standard risk calculators; you need to tell your doctor about them.
  • The most effective measures are free: Stopping smoking (the single biggest effect), 150 minutes a week of moderate activity, resistance exercise, a diet built around vegetables, legumes and whole grains, limiting salt and alcohol, and fixing your sleep.
  • Don't be afraid of medication: If blood pressure treatment or a statin is needed, that is not a failure of lifestyle — it is risk being managed. You make the decision with your doctor.
  • Decide about HRT for your symptoms, not for your heart: If HRT is being considered for your symptoms, your heart risk is part of that decision; if you have no symptoms, HRT is not a tool for your heart.

Get emergency help if you see these

  • Pressure, tightness or burning in the chest; pain spreading to the jaw, back or left arm; not relieved by rest.
  • Sudden breathlessness, cold sweat, nausea, unexplained intense weakness; especially when they occur together.
  • Sudden difficulty speaking, asymmetry of the face, weakness in an arm or leg, a severe headache; signs of a stroke.
  • Swelling and pain in one leg together with breathlessness; a possible clot.

These signs should be assessed without delay.

Sources

  1. El Khoudary SR, et al. Menopause transition and cardiovascular disease risk: AHA scientific statement. Circulation. 2020;142(25):e506-e532.
  2. Zhu D, et al. Age at natural menopause and risk of incident cardiovascular disease: pooled analysis. Lancet Public Health. 2019;4(11):e553-e564.
  3. US Preventive Services Task Force. Hormone therapy for the primary prevention of chronic conditions. JAMA. 2022;328(17):1740-1746.
  4. The Menopause Society. The 2022 Hormone Therapy Position Statement. Menopause. 2022;29(7):767-794.
  5. Visseren FLJ, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337.
  6. Makary MA, et al. Updated labeling for menopausal hormone therapy. JAMA. 2025; doi:10.1001/jama.2025.22259. FDA press release, 10 November 2025.
  7. Panay N, et al. International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopause. Climacteric. 2025;28(6):634-656.

What you can ask your doctor

  • How often should my blood pressure, cholesterol and blood sugar be measured at this stage?
  • Does a history of pregnancy complications (pre-eclampsia, gestational diabetes) or early menopause affect my heart risk?
  • Do I need medication to lower my heart risk, or is lifestyle enough?

Related articles

This content is for information only; it does not replace medical advice, diagnosis or treatment. The assessment and treatment of cardiovascular risk is done only with your doctor. If you have emergency symptoms, go to emergency care without delay.

← Home